Anti-2019-nCoV Spike mAb (IgG&IgM Positive Control)
Beta LifeScience
SKU/CAT #: BLSN-012M
Anti-2019-nCoV Spike mAb (IgG&IgM Positive Control)
Beta LifeScience
SKU/CAT #: BLSN-012M
Collections: Antibodies
Our products are highly customizable to meet your specific needs. You can choose options such as endotoxin removal, liquid or lyophilized forms, preferred tags, and the desired functional sequence range for proteins. Submitting a written inquiry expedites the quoting process.
Product Overview
Host Species | 2019-nCoV |
Background | 2019 Novel Coronavirus (2019-nCoV) is a virus (more specifically, a coronavirus) identified as the cause of an outbreak of respiratory illness first detected in Wuhan, China. |
Description | The Anti-SARS-COV2 / 2019-nCoV Spike mAb (IgG&IgM Positive Control) product contains two isotype antibody clone Human IgG and IgM, which can recognizes 2019-nCoV S-RBD Protein. It is cultrued in vitro under conditions free from animal derived components. |
Source | Vitro |
Formulation | This product contains anti-2019-nCoV S1 Antibody(Human IgG Clone#5D9) 1ml and anti-2019-nCoV S1 Antibody(Human IgM Clone#9E8) 1ml |
Usage | Anti-2019-nCoV Spike mAb (IgG&IgM Positive Control) is intended for in vitro diagnostic use in the quality control of serum on clinical chemistry and immunoassay systems. The assayed liquid protein controls are for the control of accuracy. |
Storage | Store at 4°C if entire vial will be used within 1 month. Store, frozen at -20°C for longer periods of time. Avoid repeated freeze-thaw cycles. |